Artificial Intelligence in Medical Writing Market Players:
- Artos
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- CureMetrix, Inc.
- Epic Systems Corporation
- Freyr
- GENINVO
- GNS Healthcare, Inc.
- IBM Corporation
- Parexel International (MA) Corporation
- Pearson
- TrialAssure
- Trilogy Writing & Consulting GmbH
- Yseop
AI in medical writing market companies are forming strategic partnerships with healthcare and pharmaceutical firms, developing specialized AI tools for regulatory compliance, and focusing on product innovation with custom AI models for medical documentation. The prominent players are also expanding globally, particularly in high-growth regions including APAC. Acquisitions of AI startups are common to enhance capabilities, while companies provide training and support services to ensure the smooth adoption of AI solutions in clinical trials and regulatory processes.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of artificial intelligence in medical writing is assessed at USD 974.49 million.
The global artificial intelligence in medical writing market size surpassed USD 878.08 million in 2025 and is projected to witness a CAGR of over 12.2%, crossing USD 2.78 billion revenue by 2035.
North America artificial intelligence (AI) in medical writing market will account for 39.20% share by 2035, driven by the region’s strong healthcare infrastructure, substantial R&D investments, and regulatory demands for accurate and timely medical documentation.
Key players in the market include IBM Corporation, Google LLC, Microsoft Corporation, OpenAI, Inc., Linguamatics (IQVIA), Nuance Communications, Inc. (Microsoft), Health Fidelity (Edifecs), Clinithink Ltd., Saama Technologies, Inc., Narrative Science (Tableau/Salesforce).
